Shares of Novavax Inc. NVAX shed 5.13% to $7.95 Tuesday, on what proved to be an all-around poor trading session for the ...

Novavax Inc. closed 64.88% below its 52-week high of $23.86, which the company reached on June 6th.

In the closing of the recent trading day, Novavax (NVAX) stood at $7.91, denoting a -0.57% change from the preceding trading day.

Bank of New York Mellon Corp lifted its stake in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 0.4% during the ...

Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is ...

BMC, a TMR-based vaccine manufacturer, has cancelled a contract with American biotech firm Novavax almost five years to the ...

Novavax performed well last year, but the company's shares are down significantly over the past three years and are not far ...

Starting from April 8, people aged 65 and older, indigenous people aged 55 to 64, children younger than six months old and ...

Back in November 2023, pharmaphorum travelled to Uppsala, Sweden, for a Novavax press conference, the company celebrating a decade of doing what it does best: vaccines. From COVID-19 to malaria ...

Novavax’s COVID-19 vaccine produced higher levels of neutralising antibodies than produced by recovered patients in an early trial, paving the way for a phase 3 trial and potential approval by ...

Dr Weldon, a physician who has criticised vaccines, is the first Trump nominee withdrawn from consideration. Read more at ...